NCB seizes Rs 9.2 crore assets of ‘prime accused’ in transnational drugs trafficking case from Noida

The Narcotics Control Bureau (NCB) on Sunday said it has attached a flat and a factory premises worth ₹9.20 crore in Uttar Pradesh’s Noida of a “prime” accused involved in a 2024 transnational drugs trafficking case linked to a Mexican cartel.

The agency said in a statement that it had recently secured a confirmation on the attachment from the designated competent authority and administrator constituted under the Smugglers and Foreign Exchange Manipulators (Forfeiture of Property) Act and the Narcotic Drugs and Psychotropic Substances Act.

The case pertains to the seizure of more than 95 kg of amphetamine and the unearthing of a clandestine narcotics manufacturing laboratory in Noida near Delhi in October last year.

Five people, including a Tihar Jail warden, a Mexican national part of a drug cartel operating from that country, a Mumbai-based chemist and two Delhi-based businessmen, were arrested by the NCB then.

The agency, as part of the probe, attached immovable assets of the “prime accused” in the case.

These include a luxury apartment in Jaypee Greens residential society and a factory premises in Kasna Industrial Area of Gautam Budh Nagar (Uttar Pradesh), which were “acquired using proceeds from international narcotics trafficking”, the NCB said.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit